The role of the basic helix-loop-helix transcription factor Dec1 in the regulatory T cells

Journal of Immunology

Volumn 185, Issue 12, 2010, Pages 7330-7339

  Miyazaki, Kazuko ^a,f   Miyazaki, Masaki ^b,f   Guo, Yun ^b   Yamasaki, Norimasa ^a   Kanno, Masamoto ^b   Honda, Zen Ichiro ^c   Oda, Hideaki ^d   Kawamoto, Hiroshi ^e   Honda, Hiroaki ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^e INST OF PHYS AND CHEMICAL RESEARCH   (Japan)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; INTERLEUKIN 2 RECEPTOR ALPHA; TRANSCRIPTION FACTOR DEC1; TRANSCRIPTION FACTOR RUNX1; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ARTICLE; CELL MATURATION; CELL SURVIVAL; CONTROLLED STUDY; EFFECTOR CELL; HOMEOSTASIS; INFLAMMATION; LYMPHOCYTOPENIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; THYMOCYTE; UPREGULATION;

ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL SURVIVAL; CORE BINDING FACTOR ALPHA 2 SUBUNIT; HOMEODOMAIN PROTEINS; HOMEOSTASIS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MICE; MICE, TRANSGENIC; PROTEIN BINDING; T-LYMPHOCYTES, REGULATORY; UP-REGULATION;

EID: 78650670349     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1001381     Document Type: Article

References (51)

1. Sakaguchi, S., M. Ono, R. Setoguchi, H. Yagi, S. Hori, Z. Fehervari, J. Shimizu, T. Takahashi, and T. Nomura. 2006. Foxp3+CD25+CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol. Rev. 212:8-27.
2. Sakaguchi, S., N. Sakaguchi, M. Asano, M. Itoh, and M. Toda. 1995. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor a-chains (CD25): breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155:1151-1164.
3. Josefowicz, S. Z., and A. Rudensky. 2009. Control of regulatory T cell lineage commitment and maintenance. Immunity 30:616-625.
4. Sakaguchi, S., T. Yamaguchi, T. Nomura, and M. Ono. 2008. Regulatory T cells and immune tolerance. Cell 133:775-787.
5. Hori, S., T. Nomura, and S. Sakaguchi. 2003. Control of regulatory T cell development by the transcription factor Foxp3. Science 299:1057-1061.
6. Fontenot, J. D., M. A. Gavin, and A. Y. Rudensky. 2003. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 4:330-336.
7. Khattri, R., T. Cox, S. A. Yasayko, and F. Ramsdell. 2003. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat. Immunol. 4:337-342.
8. Williams, L. M., and A. Y. Rudensky. 2007. Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3. Nat. Immunol. 8:277-284.
9. Shevach, E. M. 2009. Mechanisms of foxp3+ T regulatory cell-mediated suppression. Immunity 30:636-645.
10. Willerford, D. M., J. Chen, J. A. Ferry, L. Davidson, A. Ma, and F. W. Alt. 1995. Interleukin-2 receptor a chain regulates the size and content of the peripheral lymphoid compartment. Immunity 3:521-530.
11. Fontenot, J. D., J. P. Rasmussen, M. A. Gavin, and A. Y. Rudensky. 2005. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat. Immunol. 6:1142-1151.
12. Furtado, G. C., M. A. Curotto de Lafaille, N. Kutchukhidze, and J. J. Lafaille. 2002. Interleukin 2 signaling is required for CD4+ regulatory T cell function. J. Exp. Med. 196:851-857.
13. Setoguchi, R., S. Hori, T. Takahashi, and S. Sakaguchi. 2005. Homeostatic maintenance of natural Foxp3+CD25+CD4+ regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization. J. Exp. Med. 201:723-735.
14. Malek, T. R. 2008. The biology of interleukin-2. Annu. Rev. Immunol. 26:453-479.
15. Lin, W., D. Haribhai, L. M. Relland, N. Truong, M. R. Carlson, C. B. Williams, and T. A. Chatila. 2007. Regulatory T cell development in the absence of functional Foxp3. Nat. Immunol. 8:359-368.
16. Honma, S., T. Kawamoto, Y. Takagi, K. Fujimoto, F. Sato, M. Noshiro, Y. Kato, and K. Honma. 2002. Dec1 and Dec2 are regulators of the mammalian molecular clock. Nature 419:841-844.
17. Rossner, M. J., H. Oster, S. P. Wichert, L. Reinecke, M. C. Wehr, J. Reinecke, G. Eichele, R. Taneja, and K. A. Nave. 2008. Disturbed clockwork resetting in Sharp-1 and Sharp-2 single and double mutant mice. PLoS One 3: e2762.
18. Boudjelal, M., R. Taneja, S. Matsubara, P. Bouillet, P. Dolle, and P. Chambon. 1997. Overexpression of Stra13, a novel retinoic acid-inducible gene of the basic helix-loop-helix family, inhibits mesodermal and promotes neuronal differentiation of P19 cells. Genes Dev. 11:2052-2065.
19. Miyazaki, K., T. Kawamoto, K. Tanimoto, M. Nishiyama, H. Honda, and Y. Kato. 2002. Identification of functional hypoxia response elements in the promoter region of the DEC1 and DEC2 genes. J. Biol. Chem. 277:47014-47021.
20. Zawel, L., J. Yu, C. J. Torrance, S. Markowitz, K. W. Kinzler, B. Vogelstein, and S. Zhou. 2002. DEC1 is a downstream target of TGF-b with sequence-specific transcriptional repressor activities. Proc. Natl. Acad. Sci. USA 99:2848-2853.
21. Kon, N., T. Hirota, T. Kawamoto, Y. Kato, T. Tsubota, and Y. Fukada. 2008. Activation of TGF-b/activin signalling resets the circadian clock through rapid induction of Dec1 transcripts. Nat. Cell Biol. 10:1463-1469.
22. Ehata, S., A. Hanyu, M. Hayashi, H. Aburatani, Y. Kato, M. Fujime, M. Saitoh, K. Miyazawa, T. Imamura, and K. Miyazono. 2007. Transforming growth factor-β promotes survival of mammary carcinoma cells through induction of antiapoptotic transcription factor DEC1. Cancer Res. 67:9694-9703.
23. Sun, H., B. Lu, R. Q. Li, R. A. Flavell, and R. Taneja. 2001. Defective T cell activation and autoimmune disorder in Stra13-deficient mice. Nat. Immunol. 2:1040-1047.
24. Miyazaki, M., K. Miyazaki, M. Itoi, Y. Katoh, Y. Guo, R. Kanno, Y. Katoh-Fukui, H. Honda, T. Amagai, M. van Lohuizen, et al. 2008. Thymocyte proliferation induced by pre-T cell receptor signaling is maintained through polycomb gene product Bmi-1-mediated Cdkn2a repression. Immunity 28:231-245.
25. Ono, M., H. Yaguchi, N. Ohkura, I. Kitabayashi, Y. Nagamura, T. Nomura, Y. Miyachi, T. Tsukada, and S. Sakaguchi. 2007. Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1. Nature 446:685-689.
26. Watanabe-Fukunaga, R., C. I. Brannan, N. G. Copeland, N. A. Jenkins, and S. Nagata. 1992. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356:314-317.
27. Dianzani, U., A. Chiocchetti, and U. Ramenghi. 2003. Role of inherited defects decreasing Fas function in autoimmunity. Life Sci. 72:2803-2824.
28. Floess, S., J. Freyer, C. Siewert, U. Baron, S. Olek, J. Polansky, K. Schlawe, H. D. Chang, T. Bopp, E. Schmitt, et al. 2007. Epigenetic control of the foxp3 locus in regulatory T cells. PLoS Biol. 5: e38.
29. Bettelli, E., Y. Carrier, W. Gao, T. Korn, T. B. Strom, M. Oukka, H. L. Weiner, and V. K. Kuchroo. 2006. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441:235-238.
30. Mangan, P. R., L. E. Harrington, D. B. O'Quinn, W. S. Helms, D. C. Bullard, C. O. Elson, R. D. Hatton, S. M. Wahl, T. R. Schoeb, and C. T. Weaver. 2006. Transforming growth factor-b induces development of the T (H) 17 lineage. Nature 441:231-234.
31. Kim, H. P., J. Imbert, and W. J. Leonard. 2006. Both integrated and differential regulation of components of the IL-2/IL-2 receptor system. Cytokine Growth Factor Rev. 17:349-366.
32. St-Pierre, B., G. Flock, E. Zacksenhaus, and S. E. Egan. 2002. Stra13 homodimers repress transcription through class B E-box elements. J. Biol. Chem. 277:46544-46551.
33. Collins, A., D. R. Littman, and I. Taniuchi. 2009. RUNX proteins in transcription factor networks that regulate T-cell lineage choice. Nat. Rev. Immunol. 9:106-115.
34. Dawson, S. R., D. L. Turner, H. Weintraub, and S. M. Parkhurst. 1995. Specificity for the hairy/enhancer of split basic helix-loop-helix (bHLH) proteins maps outside the bHLH domain and suggests two separable modes of transcriptional repression. Mol. Cell. Biol. 15:6923-6931.
35. + T cells. Nat. Immunol. 8:1353-1362.
36. Marie, J. C., J. J. Letterio, M. Gavin, and A. Y. Rudensky. 2005. TGF-b1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells. J. Exp. Med. 201:1061-1067.
37. Wing, K., Y. Onishi, P. Prieto-Martin, T. Yamaguchi, M. Miyara, Z. Fehervari, T. Nomura, and S. Sakaguchi. 2008. CTLA-4 control over Foxp3+ regulatory T cell function. Science 322:271-275.
38. Mabarrack, N. H., N. L. Turner, and G. Mayrhofer. 2008. Recent thymic origin, differentiation, and turnover of regulatory T cells. J. Leukoc. Biol. 84:1287-1297.
39. Sharfe, N., H. K. Dadi, M. Shahar, and C. M. Roifman. 1997. Human immune disorder arising from mutation of the a chain of the interleukin-2 receptor. Proc. Natl. Acad. Sci. USA 94:3168-3171. (Pubitemid 27157282)
40. Lio, C. W., and C. S. Hsieh. 2008. A two-step process for thymic regulatory T cell development. Immunity 28:100-111.
41. Yao, Z., Y. Kanno, M. Kerenyi, G. Stephens, L. Durant, W. T. Watford, A. Laurence, G. W. Robinson, E. M. Shevach, R. Moriggl, et al. 2007. Nonredundant roles for Stat5a/b in directly regulating Foxp3. Blood 109:4368-4375.
42. 3+ regulatory T cells. J. Immunol. 178:280-290.
43. Komatsu, N., M. E. Mariotti-Ferrandiz, Y. Wang, B. Malissen, H. Waldmann, and S. Hori. 2009. Heterogeneity of natural Foxp3+ T cells: a committed regulatory T-cell lineage and an uncommitted minor population retaining plasticity. Proc. Natl. Acad. Sci. USA 106:1903-1908.
44. Dear, T. N., T. Hainzl, M. Follo, M. Nehls, H. Wilmore, K. Matena, and T. Boehm. 1997. Identification of interaction partners for the basic-helix-loophelix protein E47. Oncogene 14:891-898.
45. Murre, C. 2005. Helix-loop-helix proteins and lymphocyte development. Nat. Immunol. 6:1079-1086.
46. Schwartz, R., I. Engel, M. Fallahi-Sichani, H. T. Petrie, and C. Murre. 2006. Gene expression patterns define novel roles for E47 in cell cycle progression, cytokine-mediated signaling, and T lineage development. Proc. Natl. Acad. Sci. USA 103:9976-9981.
47. Fujii, M., K. Hayashi, M. Niki, N. Chiba, K. Meguro, K. Endo, J. Kameoka, S. Ito, K. Abe, T. Watanabe, and M. Satake. 1998. Overexpression of AML1 renders a T hybridoma resistant to T cell receptor-mediated apoptosis. Oncogene 17:1813-1820.
48. Egawa, T., R. E. Tillman, Y. Naoe, I. Taniuchi, and D. R. Littman. 2007. The role of the Runx transcription factors in thymocyte differentiation and in homeostasis of naive T cells. J. Exp. Med. 204:1945-1957.
49. 3+ regulatory T cells. Immunity 31:609-620.
50. Rudra, D., T. Egawa, M. M. Chong, P. Treuting, D. R. Littman, and A. Y. Rudensky. 2009. Runx-CBFb complexes control expression of the transcription factor Foxp3 in regulatory T cells. Nat. Immunol. 10:1170-1177.
51. Yang, X. O., P. Angkasekwinai, J. Zhu, J. Peng, Z. Liu, R. Nurieva, X. Liu, Y. Chung, S. H. Chang, B. Sun, and C. Dong. 2009. Requirement for the basic helix-loop-helix transcription factor Dec2 in initial TH2 lineage commitment. Nat. Immunol. 10:1260-1266.